United Kingdom Biobank (UK Biobank)

Journal article

An increasing number of people are now living with cardiovascular disease (CVD), with concomitant CVD-related hospitalisations, operations and prescriptions. To ultimately deliver optimal cardiovascular care, access to population-based biobanks with data on multi-omics, phenotypes, and lifestyle risk factors are crucial. UK Biobank is a cohort study that incorporated data between 2006 and 2010 from over half a million individuals (40–69 years) at recruitment from across the UK. As one of the most accessible, largest and in-depth cohort studies in the world, UK Biobank continues to enhance the resource with the addition of data from various - omics platforms (e.g. genomics, metabolomics, proteomics), multi-modal imaging, selfreported risk factors and health outcomes, and linkage to electronic health records. The vision of UK Biobank is to allow as many researchers as possible to apply their expertise and imagination to undertake research to prevent, diagnose and treat a wide range of chronic conditions, including CVD.

Authors: Caleyachetty, R; Littlejohns, T; Lacey, B; Bešević, J; Conroy, M

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Elsevier
• Journal: Journal of the American College of Cardiology
• Volume: 78
• Issue: 1
• Pages: 56-65
• Publication date: 2021-07-01
• Acceptance date: 2021-05-04
• DOI: 10.1016/j.jacc.2021.03.342
• EISSN: 1558-3597
• ISSN: 0735-1097
• Language: English
• Keywords: cardiovascular diseases; biobanks; cohort